Clinical Trials in Miami

Showing 2321-2340 of 9,821 trials

Diagnosis of mTBI in a Community Setting

NCT03539848

The purpose of this research study is to test whether a portable goggle system (I-PAS) is good at diagnosing mild traumatic brain injury (mTBI) in a community setting. The goal is to determine whether the IPAS goggle system can be used reliably in an urgent care or emergency department setting.

Traumatic Brain InjuryMild Traumatic Brain InjuryBrain Injuries+2 more

University of Miami120 participantsStarted Aug 2018

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

Long-Term Evaluation of BIIB067 (Tofersen)

NCT03070119

The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB067 (tofersen) in participants with amyotrophic lateral sclerosis (ALS) and confirmed superoxide dismutase 1 (SOD1) mutation. The secondary objectives are to evaluate the pharmacokinetic (PK), pharmacodynamic (PD), biomarker effects, and efficacy of BIIB067 administered to participants with ALS and a confirmed SOD1 mutation.

ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation

Biogen139 participantsStarted Mar 2017

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +27 more locations

Diagnosis of mTBI in a Community Setting

Long-Term Evaluation of BIIB067 (Tofersen)

Find Trials by Condition in Miami

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

The Effects of a Psychoeducational Intervention on Health and Performance-based Outcomes of Veterans Diagnosed With PTSD

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)